| Code | 4976D | ||||||||||
| MA number | 44/0154/20-S | ||||||||||
| Product Form: | tbl flm 60x200 mg (blis.Al/OPA/Al/PVC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.07.2020 |
| Validity: | 07.07.2025 |
| PIL: |
PIL_Sorafenib STADA_02.2023.pdf
|
| SPC: |
SPC_Sorafenib STADA_01.2024.pdf
|
| Safety feature | Yes |
| Data update: | 16.01.2024 |
